CYP1B1基因多态性与紫杉醇不良反应的相关性研究(4)
[8] 喻经纬,鲁智豪,高静,等. 紫杉醇耐药机制研究进展及研究方向[J]. 中国药学杂志,2013,48(14):1147-1150.
[9] 王健,唐金海,赵建华. 紫杉醇相关代谢酶和药物转运体基因多态性与乳腺癌化疗反应[J]. 分子诊断与治疗杂志,2010,2(1):63-67.
[10] Murray GI,Melvin WT,Greenlee WF,et al. Regulation,function,and tissue-specific expression of cytochrome P450 YP1B1[J]. Annu Rev Pharmacol Toxicol,2001,41:297-331.
[11] 陳彬尧,李玲,赵慧佳,等. CYP1B1 遗传多态性与个体化治疗[J].中国临床药理学与治疗学,2018,23(11):1309-1316.
[12] Pastina I,Giovannetti E,Chioni A,et al. Cytochrome 450 1B1(CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer(CRPC)patients[J]. BMC Cancer,2010,10(1):1-9.
[13] Joanna T,Ewa G,Janina S,et al. Variant alleles of theCYP1B1 gene are associated with colorectal cancer susceptibility[J]. BMC Cancer,2010,10:420.
[14] 杨晓琳. 乳腺癌患者CYP1B1*3基因多态性对多西他赛血液学毒性的影响[J]. 中国医药科学,2018,8(7):48-50.
[15] Rizzo R,Spaggiari F,Indelli M,et al.Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients[J].Breast Cancer Res Treat,2010,124(2):593-598., 百拇医药(许秋霞 叶磊 周细萍 陈文发 陈金成 高雅莉)
[9] 王健,唐金海,赵建华. 紫杉醇相关代谢酶和药物转运体基因多态性与乳腺癌化疗反应[J]. 分子诊断与治疗杂志,2010,2(1):63-67.
[10] Murray GI,Melvin WT,Greenlee WF,et al. Regulation,function,and tissue-specific expression of cytochrome P450 YP1B1[J]. Annu Rev Pharmacol Toxicol,2001,41:297-331.
[11] 陳彬尧,李玲,赵慧佳,等. CYP1B1 遗传多态性与个体化治疗[J].中国临床药理学与治疗学,2018,23(11):1309-1316.
[12] Pastina I,Giovannetti E,Chioni A,et al. Cytochrome 450 1B1(CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer(CRPC)patients[J]. BMC Cancer,2010,10(1):1-9.
[13] Joanna T,Ewa G,Janina S,et al. Variant alleles of theCYP1B1 gene are associated with colorectal cancer susceptibility[J]. BMC Cancer,2010,10:420.
[14] 杨晓琳. 乳腺癌患者CYP1B1*3基因多态性对多西他赛血液学毒性的影响[J]. 中国医药科学,2018,8(7):48-50.
[15] Rizzo R,Spaggiari F,Indelli M,et al.Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients[J].Breast Cancer Res Treat,2010,124(2):593-598., 百拇医药(许秋霞 叶磊 周细萍 陈文发 陈金成 高雅莉)